Cardiff Oncology (CRDF) PT Lowered to $13 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts CRDF Hot Sheet
Price: $1.02 -2.86%
Rating Summary:
7 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 6
Rating Summary:
7 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 6
Join SI Premium – FREE
H.C. Wainwright analyst Raghuram Selvaraju lowered the price target on Cardiff Oncology (NASDAQ: CRDF) to $13.00 (from $14.00) while maintaining a Buy rating.
You May Also Be Interested In
- William Blair Downgrades Cardiff Oncology (CRDF) to Market Perform
- Sumitomo Forestry Co (1911:JP) PT Lowered to JPY1,920 at Nomura/Instinet
- Cardiff Oncology Reports Second Quarter 2026 Results and Provides Business Update
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
